BioMaxima S.A.
Manufacturer of IVD solutions including tests, reagents, and equipment for medical labs.
BMX | WAR
Overview
Corporate Details
- ISIN(s):
- PLBIOMX00015
- LEI:
- 2594007GAALFMXP4YB89
- Country:
- Poland
- Address:
- Lublin Vetterów 5, 20-277 Lublin
- Website:
- https://www.biomaxima.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioMaxima S.A. is a manufacturer in the biotechnology sector specializing in the in vitro diagnostics (IVD) market. The company develops and produces a comprehensive range of solutions for laboratory diagnostics, supporting medical professionals and diagnosticians. Its portfolio encompasses microbiological media, reagents, specialized equipment, and IVD tests. Key application areas include clinical chemistry, haematology, and the diagnosis of infectious diseases, featuring systems for determining drug sensitivity and reference strains for microorganisms.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-21 14:50 |
Regulatory News Service
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 815 bytes | ||
| 2025-11-21 14:12 |
Regulatory News Service
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 951 bytes | ||
| 2025-09-30 17:15 |
Audit Report / Information
Raport Biegłego z przeglądu skróconego spawozdania jednostkowego
|
Polish | 345.0 KB | ||
| 2025-09-30 17:15 |
Audit Report / Information
Raport Biegłego z przeglądu sprawozdania skonsolidowanego
|
Polish | 348.4 KB | ||
| 2025-09-30 17:15 |
Management Discussion and Analysis
Sprawozdanie Zarządu za I półrocze 2025
|
Polish | 727.0 KB | ||
| 2025-09-30 17:15 |
Interim Report
Skonsolidowane sprawozdanie półroczne ze skróconymsprawozdaniem finansowym
|
Polish | 1.5 MB | ||
| 2025-09-30 17:15 |
Interim Report
List Prezesa Zarządu do akcjonariuszy
|
Polish | 255.8 KB | ||
| 2025-09-26 08:18 |
Regulatory News Service
Dostawa analizatora - Content (PL)
|
Polish | 663 bytes | ||
| 2025-08-27 12:45 |
Regulatory News Service
Informacja o otrzymaniu dofinansowania w kwocie 1.097.835,17 zł na rozbudowę of…
|
Polish | 1.7 KB | ||
| 2025-08-08 20:29 |
Director's Dealing
Zawiadomienie 19 MAR
|
Polish | 8.0 KB | ||
| 2025-08-08 20:29 |
Report Publication Announcement
Zawiadomienie od osoby zobowiązanej - Content (PL)
|
Polish | 213 bytes | ||
| 2025-07-15 12:07 |
Business and Financial Review
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 581 bytes | ||
| 2025-06-27 14:00 |
Regulatory News Service
Podpisanie znaczącej umowy - Content (PL)
|
Polish | 776 bytes | ||
| 2025-06-25 13:05 |
Major Shareholding Notification
zal01_Wykaz_akcjonariuszy.pdf
|
Polish | 127.8 KB | ||
| 2025-06-25 13:05 |
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów podczas WZ w dniu 25.6.…
|
Polish | 242 bytes |
Automate Your Workflow. Get a real-time feed of all BioMaxima S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BioMaxima S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BioMaxima S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
%20Inc./other/Mind_Medicine_MindMed_Inc.-logo.png){kind=logo}
